mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.074 |
0.1 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.1 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |